The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
about
Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cyclesHuman menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cyclesResults from adding recombinant LH for assisted reproductive technology treatment: A randomized control trialReduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analoguesA randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years.Requirements for human chorionic gonadotropin and recombinant human luteinizing hormone for follicular development and maturationIntracytoplasmic sperm injection after follicle stimulation with highly purified human follicle-stimulating hormone compared with human menopausal gonadotropinThe Ideal Stimulation Protocol: Is There One?"hCG priming" effect in controlled ovarian stimulation through a long protocol.The reproductive outcome of women with hypogonadotropic hypogonadism undergoing in vitro fertilization.Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women.Efficacy assessment of highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotropin during pituitary suppression in patients undergoing GIFT for unexplained infertility.Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.Low dose gonadotropin-releasing hormone agonist treatments with early discontinuation for controlled ovarian hyperstimulation in an in vitro fertilization program.
P2860
Q24234251-8BAC5E08-F94D-49B0-AEC9-97AF87BF5F55Q24250231-BB5FAF24-B490-4014-8FFB-A594D9CC837EQ33564323-26B001EC-7204-4E15-8188-E3EFBC308F77Q36267552-30048B12-EFA0-4F93-91EA-521F901C7C3CQ36269264-B41F880A-4E57-4896-9113-9C136D123ACAQ36270640-EA970919-4C70-4B7E-AF37-15856C32EEF1Q36271611-531FCEB1-3DA2-42EE-B586-E1C65A26FF55Q36337216-8A1DCDC6-1FE9-491C-B50F-4D6816D2A127Q37348506-3F1B613F-C69E-4062-910C-99018EB605A6Q48577016-F1BEA804-8113-457E-AF8C-53CF13B6898BQ48609608-B8F0A2B4-929C-410E-A6D6-2A989EA8E1E4Q48913448-6A6158AC-EC43-43A6-9F84-968402E24C6BQ48935296-CD3C7671-13C2-4431-AC31-59EE4502EA3FQ48943856-94F7C287-9770-45D4-9663-6F792E85D65CQ55069292-D6D52EBA-0B31-4003-82F6-C508DDF1E901
P2860
The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The effect of human menopausal ...... ated normogonadotrophic women.
@en
The effect of human menopausal ...... ated normogonadotrophic women.
@nl
type
label
The effect of human menopausal ...... ated normogonadotrophic women.
@en
The effect of human menopausal ...... ated normogonadotrophic women.
@nl
prefLabel
The effect of human menopausal ...... ated normogonadotrophic women.
@en
The effect of human menopausal ...... ated normogonadotrophic women.
@nl
P2093
P1433
P1476
The effect of human menopausal ...... ated normogonadotrophic women.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.HUMREP.A019357
P407
P577
1996-06-01T00:00:00Z